Lung Cancer (Non-Small Cell) Clinical Trials in London
2 recruitingLondon, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)
Lung Cancer (Non-Small Cell)
GlaxoSmithKline40 enrolled1 locationNCT06405230
Recruiting
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Lung Cancer (Non-Small Cell)Small Cell Lung CancerPleural Mesothelioma
University College, London600 enrolled1 locationNCT05628376